Shanxi Zhendong Pharmaceutical Market Cap ($698.44 Million)
Market Cap & Net Worth: Shanxi Zhendong Pharmaceutical (300158)
Shanxi Zhendong Pharmaceutical market cap. Shanxi Zhendong Pharmaceutical (SHE:300158) has a market capitalization of $698.44 Million (CN¥4.77 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #10285 globally and #2690 in its home market, demonstrating a 2.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanxi Zhendong Pharmaceutical's stock price CN¥4.81 by its total outstanding shares 992303056 (992.30 Million). Also see how efficiently does Shanxi Zhendong Pharmaceutical generate cash for how efficiently the company converts equity into cash flow.
Shanxi Zhendong Pharmaceutical Market Cap History (2015–2026)
Shanxi Zhendong Pharmaceutical market cap history from 2015 to 2026. Data shows change from $1.04 Billion to $698.44 Million (-2.81% CAGR). Check latest Shanxi Zhendong Pharmaceutical stock price today for real-time trading data and today's change.
Shanxi Zhendong Pharmaceutical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanxi Zhendong Pharmaceutical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Shanxi Zhendong Pharmaceutical (300158) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.21x
Shanxi Zhendong Pharmaceutical's market cap is 0.21 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.04 Billion | $2.26 Billion | $64.65 Million | 0.46x | 16.06x |
| 2016 | $1.04 Billion | $3.28 Billion | $203.06 Million | 0.32x | 5.12x |
| 2017 | $734.98 Million | $3.73 Billion | $301.54 Million | 0.20x | 2.44x |
| 2018 | $407.18 Million | $3.42 Billion | -$147.44 Million | 0.12x | N/A |
| 2019 | $517.28 Million | $4.40 Billion | $142.76 Million | 0.12x | 3.62x |
| 2020 | $593.03 Million | $4.85 Billion | $262.03 Million | 0.12x | 2.26x |
| 2021 | $905.59 Million | $5.09 Billion | $2.62 Billion | 0.18x | 0.35x |
| 2022 | $1.08 Billion | $3.73 Billion | -$51.29 Million | 0.29x | N/A |
| 2023 | $980.13 Million | $3.63 Billion | -$43.98 Million | 0.27x | N/A |
| 2024 | $627.29 Million | $2.97 Billion | -$1.33 Billion | 0.21x | N/A |
Competitor Companies of 300158 by Market Capitalization
Companies near Shanxi Zhendong Pharmaceutical in the global market cap rankings as of November 5, 2026. Also see 300158 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Shanxi Zhendong Pharmaceutical by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Shanxi Zhendong Pharmaceutical (2015–2026)
Market capitalization of Shanxi Zhendong Pharmaceutical from 2015 to today. Between 2015 and today, Shanxi Zhendong Pharmaceutical's market cap moved from $1.04 Billion to $ 698.44 Million, with a yearly change of -2.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥698.44 Million | -17.21% |
| 2025 | CN¥843.64 Million | +34.49% |
| 2024 | CN¥627.29 Million | -36.00% |
| 2023 | CN¥980.13 Million | -9.40% |
| 2022 | CN¥1.08 Billion | +19.46% |
| 2021 | CN¥905.59 Million | +52.70% |
| 2020 | CN¥593.03 Million | +14.64% |
| 2019 | CN¥517.28 Million | +27.04% |
| 2018 | CN¥407.18 Million | -44.60% |
| 2017 | CN¥734.98 Million | -29.31% |
| 2016 | CN¥1.04 Billion | +0.14% |
| 2015 | CN¥1.04 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Shanxi Zhendong Pharmaceutical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $698.44 Million USD |
| MoneyControl | $698.44 Million USD |
| MarketWatch | $698.44 Million USD |
| marketcap.company | $698.44 Million USD |
| Reuters | $698.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanxi Zhendong Pharmaceutical
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is b… Read more